A Phase I/II Study of Bucladesine in Patients with Severe Methylmalonic Acidemia
A Phase I/II Multi-Institutional Study of Bucladesine in Patients with Severe Methylmalonic Acidemia - McAMP A Phase I/II Multi-Institutional Study of Bucladesinein Patients with Severe Methylmalonic Acidemia ...
methylmalonic acidemia;C537358
Bucladesine will be administered intravenously over 60 minutes once a week. Starting dose is 0.3mg/kg. Dosage will be incerased to 0.55mg/kg, then 1.65mg/kg with monitoring PK and safety data. Bucladesinewill be administered intravenously over 60 minutes once a week. Starting dose is 0.3mg/kg ...